跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
盐酸哌甲酯缓释干混悬剂 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Methylphenidate Hydrochloride for Sustained-release Suspension
Approved
化学药品
Methylphenidate Hydrochloride for Sustained-release Suspension
NextWave Pharmaceuticals, Inc.
🇨🇳 National Medical Products Administration
Approval Date
Dec 29, 2023
Approval ID
8WHZYaYWq3a
Company
NextWave Pharmaceuticals, Inc.
Type
化学药品
Approval Details
Approval Id
8WHZYaYWq3a
Approval Number
国药准字HJ20230150
Generic Name
盐酸哌甲酯缓释干混悬剂
Generic Name En
Methylphenidate Hydrochloride for Sustained-release Suspension
Drug Type
化学药品
Dosage Form
口服混悬剂
Strength
300mg
Reg Date
2023-12-29
Expired Date
2028-12-28
Company Name
NextWave Pharmaceuticals, Inc.
Production Company Name
TRIS PHARMA, INC.
Company Detail Path
/organization/nextwave-pharmaceuticals-inc
Production Company Detail Path
/organization/tris-pharma-inc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Dec 29, 2023
Approval ID
8WHZYaYWq3a
Type
化学药品
Back to NMPA Approvals